Secondary Causes of Diabetes
Secondary causes of diabetes include diseases of the exocrine pancreas, endocrinopathies, drug-induced diabetes, genetic defects in β-cell function or insulin action, and infections that can lead to hyperglycemia requiring clinical intervention. 1
Diseases of the Exocrine Pancreas
- Pancreatitis (acute or chronic): Extensive pancreatic damage is typically required to cause diabetes
- Pancreatic cancer: Notably, even small adenocarcinomas can cause diabetes, suggesting mechanisms beyond simple β-cell mass reduction
- Trauma to the pancreas
- Pancreatectomy: Surgical removal of pancreatic tissue
- Cystic fibrosis: When extensive enough to damage β-cells
- Hemochromatosis: Iron overload damages pancreatic tissue
- Fibrocalculous pancreatopathy: Characterized by abdominal pain radiating to the back and pancreatic calcifications 1
Endocrinopathies
Hormones that antagonize insulin action can cause diabetes when present in excess:
- Acromegaly (excess growth hormone)
- Cushing's syndrome (excess cortisol)
- Glucagonoma (excess glucagon)
- Pheochromocytoma (excess epinephrine)
- Somatostatinoma (inhibits insulin secretion)
- Aldosteronoma (hypokalemia can inhibit insulin secretion)
Hyperglycemia typically resolves when the hormone excess is corrected. These generally occur in individuals with preexisting defects in insulin secretion. 1
Drug or Chemical-Induced Diabetes
Many medications can impair insulin secretion or action:
Glucocorticoids: High-dose steroids are among the most common causes of drug-induced diabetes 2, 3
Antipsychotics: Particularly second-generation agents like clozapine, olanzapine, and quetiapine 4, 3
Cardiovascular drugs: Including statins, beta-blockers, and thiazide diuretics 2, 5
Antiretroviral therapy: Particularly protease inhibitors 2, 3
Immunosuppressants: Including mTOR inhibitors and post-transplant medications 2
Other medications:
Toxins: Such as Vacor (rat poison) and intravenous pentamidine can permanently destroy pancreatic β-cells 1
Genetic Defects
Genetic Defects in β-cell Function
Maturity-onset diabetes of the young (MODY): Characterized by onset before age 25, autosomal dominant inheritance, and impaired insulin secretion with minimal insulin resistance
- HNF-1α mutations (chromosome 12) - most common form
- Glucokinase mutations (chromosome 7p) - affects the "glucose sensor" of β-cells
- Other transcription factor mutations: HNF-4α, HNF-1β, IPF-1, NeuroD1 1
Mitochondrial DNA mutations: Associated with diabetes and deafness, most commonly at position 3,243 in the tRNA leucine gene 1
Proinsulin conversion defects: Rare autosomal dominant traits causing mild glucose intolerance 1
Genetic Defects in Insulin Action
- Insulin receptor mutations: Ranging from hyperinsulinemia with modest hyperglycemia to severe diabetes
- Type A insulin resistance: Often with acanthosis nigricans; women may have virilization and polycystic ovaries
- Leprechaunism: Pediatric syndrome with characteristic facial features, usually fatal in infancy
- Rabson-Mendenhall syndrome: Associated with abnormalities of teeth, nails, and pineal gland hyperplasia 1
Infections
- Congenital rubella: Associated with β-cell destruction
- Certain viruses: Have been linked to β-cell damage 1
Uncommon Forms of Immune-Mediated Diabetes
- Stiff-man syndrome: Autoimmune disorder of the central nervous system with high titers of GAD autoantibodies; approximately one-third develop diabetes
- Anti-insulin receptor antibodies: Can cause diabetes by blocking insulin binding or occasionally act as insulin agonists 1
Genetic Syndromes Associated with Diabetes
- Down syndrome
- Klinefelter syndrome
- Turner syndrome
- Wolfram syndrome: Autosomal recessive disorder with insulin-deficient diabetes, diabetes insipidus, hypogonadism, optic atrophy, and neural deafness 1
Clinical Considerations
When evaluating for secondary causes of diabetes:
- Assess for clinical features suggesting specific etiologies (e.g., cushingoid features, acromegalic features)
- Review medication history thoroughly
- Consider genetic testing in young patients with atypical presentations
- Evaluate for pancreatic disease with appropriate imaging when indicated
- Screen for endocrine disorders when clinically suspected
Management Approach
The management of secondary diabetes should focus on:
- Treating the underlying cause when possible (e.g., removing the offending drug, treating the endocrinopathy)
- Standard diabetes care including lifestyle modifications and appropriate glucose-lowering medications
- Regular monitoring of glucose levels, especially when starting medications with known diabetogenic effects
For drug-induced diabetes specifically, consider decreasing the dose or selecting alternative treatments when possible 2.